The role of neuroimaging in Alzheimer's disease

Today, the role of neuroimaging in the diagnosis of Alzheimer's disease ( AD) extends beyond its traditional role of excluding other conditions such as neurosurgical lesions. Modern challenges for neuroimaging techniques aim to contribute to the early diagnosis of AD. Early diagnosis includes recognition of pre-demented conditions, such as people with mild cognitive impairment (MCI) or with high risk of developing AD. In addition, early diagnosis would allow early treatment using currently available therapies or new therapies in the future. In this article, we will present the modern role of neuroimaging in AD. Structural MRI can detect and follow the time course of medial temporal lobe atrophy as a surrogate marker for the pathological process. New MRI techniques and image analysis software can detect subtle brain diffusion, perfusion or metabolic changes thus providing new tools for studying the pathological process. New ligands are also available for studies using tracers and positron emission tomography.